Evidence map›Paper›PMID 16436204›Full record

ArticleBMC bioinformatics2006

GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease.

Alison A Motsinger, Stephen L Lee, George Mellick, Marylyn D Ritchie

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC bioinformatics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Statistical and Computational Methods for Genetic Diseases: An Overview.Computational and mathematical methods in medicine · 2015
    Review
  6. Implications of genome-wide association studies in cancer therapeutics.British journal of clinical pharmacology · 2013
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Alison A MotsingerCenter for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, TN 37232-0700, USA. alison.a.motsinger@vanderbilt.edu
Stephen L Lee
George Mellick
Marylyn D Ritchie
Center for Human Genetics · USDartmouth Psychiatric Research Center · USThe University of Queensland · AUVanderbilt University · US

Funding

PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
Vanderbilt Biomedical Informatics Training ProgramT15LM007450 · NLM · VANDERBILT UNIVERSITY · PI Jessica S. Ancker, Bradley A. Malin · 2002 to 2026
$19.7M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Revealing Epistasis in Alzheimer DiseaseR01AG020135 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARTIN, EDEN R. · 2002 to 2006
$2.7M
Genetics Training Program: Implications of VariationT32GM062758 · NIGMS · VANDERBILT UNIVERSITY · PI PHILLIPS III, JOHN ATLAS · 2001 to 2005
$946k
NHLBI NIH HHS HL65962NHLBI NIH HHS U01 HL065962NHLBI NIH HHS U19 HL065962NIA NIH HHS AG20135NIA NIH HHS R01 AG020135NIGMS NIH HHS GM62758NIGMS NIH HHS T32 GM062758NLM NIH HHS LM007450NLM NIH HHS T15 LM007450
6 · The paper itself

Abstract

backgroundThe identification and characterization of genes that influence the risk of common, complex multifactorial disease primarily through interactions with other genes and environmental factors remains a statistical and computational challenge in genetic epidemiology. We have previously introduced a genetic programming optimized neural network (GPNN) as a method for optimizing the architecture of a neural network to improve the identification of gene combinations associated with disease risk. The goal of this study was to evaluate the power of GPNN for identifying high-order gene-gene interactions. We were also interested in applying GPNN to a real data analysis in Parkinson's disease.

resultsWe show that GPNN has high power to detect even relatively small genetic effects (2-3% heritability) in simulated data models involving two and three locus interactions. The limits of detection were reached under conditions with very small heritability (<1%) or when interactions involved more than three loci. We tested GPNN on a real dataset comprised of Parkinson's disease cases and controls and found a two locus interaction between the DLST gene and sex.

conclusionThese results indicate that GPNN may be a useful pattern recognition approach for detecting gene-gene and gene-environment interactions.

Indexed as

AlgorithmsNeural Networks, ComputerChromosome MappingDiagnosis, Computer-AssistedGene Expression ProfilingGenetic Predisposition to DiseaseGenetic TestingHumansMultigene FamilyParkinson DiseasePattern Recognition, AutomatedPolymorphism, Single NucleotideProtein Interaction Mapping

Identifiers

PMID16436204
PMCPMC1388239
OpenAlexW2150531171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.